Anebulo Pharmaceuticals (ANEB) Stock Forecast, Price Target & Predictions
ANEB Stock Forecast
Anebulo Pharmaceuticals stock forecast is as follows: an average price target of $6.00 (represents a 188.46% upside from ANEB’s last price of $2.08) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
ANEB Price Target
ANEB Analyst Ratings
Anebulo Pharmaceuticals Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Sep 18, 2023 | Boobalan Pachaiyappan | H.C. Wainwright | $6.00 | $3.27 | 83.49% | 188.46% |
Anebulo Pharmaceuticals Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $6.00 |
Last Closing Price | $2.08 | $2.08 | $2.08 |
Upside/Downside | -100.00% | -100.00% | 188.46% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Sep 18, 2023 | H.C. Wainwright | - | Buy | Initialise |
Anebulo Pharmaceuticals Financial Forecast
Anebulo Pharmaceuticals Revenue Forecast
Oct 24 | Jul 24 | Mar 24 | |
---|---|---|---|
Revenue | - | - | - |
Avg Forecast | - | - | - |
High Forecast | - | - | - |
Low Forecast | - | - | - |
# Analysts | 2 | 2 | 3 |
Surprise % | - | - | - |
Anebulo Pharmaceuticals EBITDA Forecast
Oct 24 | Jul 24 | Mar 24 | |
---|---|---|---|
# Analysts | 2 | 2 | 3 |
EBITDA | - | - | - |
Avg Forecast | - | - | - |
High Forecast | - | - | - |
Low Forecast | - | - | - |
Surprise % | - | - | - |
Anebulo Pharmaceuticals Net Income Forecast
Oct 24 | Jul 24 | Mar 24 | |
---|---|---|---|
# Analysts | 2 | 2 | 3 |
Net Income | - | - | - |
Avg Forecast | $39.97M | $-2.85M | $-3.03M |
High Forecast | $39.97M | $-2.85M | $-3.03M |
Low Forecast | $39.97M | $-2.85M | $-3.03M |
Surprise % | - | - | - |
Anebulo Pharmaceuticals SG&A Forecast
Oct 24 | Jul 24 | Mar 24 | |
---|---|---|---|
# Analysts | 2 | 2 | 3 |
SG&A | - | - | - |
Avg Forecast | - | - | - |
High Forecast | - | - | - |
Low Forecast | - | - | - |
Surprise % | - | - | - |
Anebulo Pharmaceuticals EPS Forecast
Oct 24 | Jul 24 | Mar 24 | |
---|---|---|---|
# Analysts | 2 | 2 | 3 |
EPS | - | - | - |
Avg Forecast | $1.54 | $-0.11 | $-0.12 |
High Forecast | $1.54 | $-0.11 | $-0.12 |
Low Forecast | $1.54 | $-0.11 | $-0.12 |
Surprise % | - | - | - |
Anebulo Pharmaceuticals Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
PMVP | PMV Pharmaceuticals | $1.51 | $24.75 | 1539.07% | Buy |
ANTX | AN2 Therapeutics | $1.04 | $8.75 | 741.35% | Buy |
AVTE | Aerovate Therapeutics | $1.90 | $13.00 | 584.21% | Hold |
MOLN | Molecular Partners | $5.22 | $29.00 | 455.56% | Buy |
OPT | Opthea | $3.15 | $14.00 | 344.44% | Buy |
ANEB | Anebulo Pharmaceuticals | $2.08 | $6.00 | 188.46% | Buy |
MLYS | Mineralys Therapeutics | $11.76 | $30.00 | 155.10% | Buy |
ACRV | Acrivon Therapeutics | $8.91 | $21.50 | 141.30% | Buy |
ADAG | Adagene | $3.49 | $5.00 | 43.27% | Buy |
ANAB | AnaptysBio | $40.33 | $36.33 | -9.92% | Buy |
ANEB Forecast FAQ
Is Anebulo Pharmaceuticals a good buy?
Yes, according to 1 Wall Street analysts, Anebulo Pharmaceuticals (ANEB) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of ANEB's total ratings.
What is ANEB's price target?
Anebulo Pharmaceuticals (ANEB) average price target is $6 with a range of $6 to $6, implying a 188.46% from its last price of $2.08. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Anebulo Pharmaceuticals stock go up soon?
According to Wall Street analysts' prediction for ANEB stock, the company can go up by 188.46% (from the last price of $2.08 to the average price target of $6), up by 188.46% based on the highest stock price target, and up by 188.46% based on the lowest stock price target.
Can Anebulo Pharmaceuticals stock reach $3?
ANEB's average twelve months analyst stock price target of $6 supports the claim that Anebulo Pharmaceuticals can reach $3 in the near future.